Detalhe da pesquisa
1.
Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.
J Clin Microbiol
; 54(1): 25-34, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26311858
2.
Risk Factors for Primary Clostridium difficile Infection; Results From the Observational Study of Risk Factors for Clostridium difficile Infection in Hospitalized Patients With Infective Diarrhea (ORCHID).
Front Public Health
; 8: 293, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32766196
3.
A Longitudinal Epidemiology Study of Meningococcal Carriage in Students 13 to 25 Years Old in Quebec.
mSphere
; 3(6)2018 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30518675
4.
A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults.
Vaccine
; 34(18): 2082-91, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26993331
5.
Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy.
J Infect
; 71(1): 43-52, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25709085
6.
Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.
J Acquir Immune Defic Syndr
; 59(1): 1-9, 2012 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21963936
7.
Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.
Vaccine
; 28(43): 7016-24, 2010 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-20728522
8.
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.
Vaccine
; 25(3): 510-8, 2007 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-17049679
9.
European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research.
Vaccine
; 23(48-49): 5551-6, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16153752